Status:
UNKNOWN
Solid Organ Transplant Recipients With SARS-CoV-2 French Registry
Lead Sponsor:
University Hospital, Strasbourg, France
Conditions:
SARS-CoV-2
Eligibility:
All Genders
1+ years
Brief Summary
Patients with comorbid condition are known to be at high risk of severe forms of Covid-19. It is highly probable that immunocompromised patients like solid organ transplant (SOT) recipients are also a...
Eligibility Criteria
Inclusion
- All Solid Organ Transplant recipients with a functioning graft and a high suspicion or a confirmed SARS-CoV-2 infection
- Adult and pediatric
Exclusion
- \- There are no exclusion criteria, except for the patient's explicit refusal to participate
Key Trial Info
Start Date :
April 8 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 8 2021
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT04360707
Start Date
April 8 2020
End Date
April 8 2021
Last Update
May 5 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Service de Néphrologie et Transplantation
Strasbourg, France, 67091